Assessment of glycemic gap as a biomarker of severity and outcome of pulmonary embolism in diabetic patients

Objective The aim was to assess the role of glycemic gap as a biomarker of pulmonary embolism severity and outcome in diabetic patients. Patients Diabetic patients who were 18 years of age or older admitted with confirmed diagnosis of pulmonary embolism (n=280) were included in the study. Methods On...

Full description

Saved in:
Bibliographic Details
Published in:The Egyptian journal of chest diseases and tuberculosis 2018-10, Vol.67 (4), p.406-412
Main Authors: Shebl, Eman, Abbas, Ahmad
Format: Article
Language:English
Subjects:
diabetes mellitus
glucose
mortality
pulmonary embolism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective The aim was to assess the role of glycemic gap as a biomarker of pulmonary embolism severity and outcome in diabetic patients. Patients Diabetic patients who were 18 years of age or older admitted with confirmed diagnosis of pulmonary embolism (n=280) were included in the study. Methods On admission, blood glucose level was measured. HbA1c was measured. To convert HbA1c levels to the estimated long-term average glucose levels (eAG) for the previous 3 months, the equation AG = 28.7×HbA1c-46.7 was used. From the glucose level at ED admission minus the eAG, the glycemic gap was calculated. The severity of pulmonary embolism was assessed by the pulmonary embolism severity index (PESI). Results There was a significant positive correlation between glycemic gap and the severity of pulmonary embolism and length of hospital stay. There was a significant difference of the glycemic gap between nonsurvivors and survivors (110.3±35.6 vs.48.8±31.3; P
ISSN:0422-7638
2090-9950
DOI:10.4103/ejcdt.ejcdt_97_18